<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01274988</url>
  </required_header>
  <id_info>
    <org_study_id>NACDBS</org_study_id>
    <nct_id>NCT01274988</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation of Nucleus Accumbens to Prevent Opiate Relapse</brief_title>
  <official_title>Deep Brain Stimulation of Nucleus Accumbens as a New Treatment to Prevent Relapse for Opiate Addicts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nucleus accumbens plays important roles in the process of opiate addiction and initial of
      relapse after detoxification, deep brain stimulation of nucleus accumbens will inhibit its
      activity and thus to effectively prevent the relapse of the opiate dependence.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment retention</measure>
    <time_frame>12 months</time_frame>
    <description>Opiate abstinent time by self-reports and monthly urinalysis for the patients undergo the deep brain stimulation of nucleus accumbens,treatment retention time for the methadone maintenance treatment patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of participants' craving for opioid drugs</measure>
    <time_frame>Baseline, 3 month, 6 month and 12month follow-up assessments</time_frame>
    <description>The 10-point visual analog scale (VAS),will be utilized at each time point. A participants' diary will be utilized at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Addiction Severity Index (ASI lite) composite scores</measure>
    <time_frame>Baseline, 3 month, 6 month and 12month follow-up assessments</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological evaluation</measure>
    <time_frame>Baseline, 3 month, 6 month and 12month follow-up assessments</time_frame>
    <description>The Symptom Checklist - 90 (SCL-90) for evaluating general status, Self-Rating Depression Scale (SDS)for evaluating depression symptom,and Yale-Brown Obsessive Compulsive Scale (Y-BOCS) for evaluating obsessive compulsive symptom, will be utilized at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Personality evaluation</measure>
    <time_frame>Baseline, 3 month, 6 month and 12month follow-up assessments</time_frame>
    <description>The Eysenck Personality Questionnaire (EPQ)will be utilized at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive evaluation</measure>
    <time_frame>Baseline, 3 month, 6 month and 12month follow-up assessments</time_frame>
    <description>The Wechsler Memory Scale(WMS) for evaluating the memory will be utilized at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of quality of life</measure>
    <time_frame>Baseline, 3 month, 6 month and 12 month follow-up assessments</time_frame>
    <description>The MOS item short from health survey(SF-36) be utilized at each time point.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in two static positron emission tomography(PET) images study</measure>
    <time_frame>Baseline and 6month follow-up</time_frame>
    <description>[18F]fluoro-D-glucose (FDG) for evaluating cerebral metabolism will be utilized at each time point.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Addiction</condition>
  <arm_group>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous deep brain stimulation of bilateral nucleus accumbens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>methadone maintenance treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Deep brain stimulation</intervention_name>
    <description>Deep brain stimulation of bilateral nucleus accumbens</description>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>methadone maintenance treatment</intervention_name>
    <description>methadone maintenance treatment</description>
    <arm_group_label>Standard Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old

          -  Long lasting heroin addiction (fulfilled diagnostic-criteria according to ICD-10)

          -  At least three detoxication-treatments without a long-term period of abstinence has
             already taken place

          -  Long-term inpatient treatment to support abstinence have occurred

          -  completion of detoxification treatment preoperatively with no somatic symptoms of
             withdrawal

          -  negative morphine urinalysis and naloxone tests

          -  Free patient's decision/informed Consent (existing comprehensive ability in meaning,
             methodology and execution of the study and ability of acceptance)

        Exclusion Criteria:

          -  Clinical relevant psychiatric comorbidity (schizophrenic psychoses, bipolar affective
             diseases, severe personality disorder)

          -  Contraindications of a MRI-examination, e.g. implanted cardiac pacemaker/heart
             defibrillator

          -  Current and in the last six months existent paranoid-hallucinated symptomatology

          -  Foreign aggressiveness in the last six months

          -  Stereotactic respectively neurosurgical intervention in the past

          -  Contraindications of a stereotactic operation, e.g. increased bleeding-disposition,
             cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular
             diseases)

          -  Serious and instable organic diseases (e.g. instable coronal heart disease)

          -  tested positively for HIV

          -  pregnancy and/or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guo-dong Gao, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of neurosurgery, Tangdu Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guo-dong Gao, M.D.</last_name>
    <phone>+86 29 84777435</phone>
    <email>gguodong@fmmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xue-lian Wang, M.D.</last_name>
    <phone>+86 29 84777284</phone>
    <email>wxlian@fmmu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of neurosurgery, Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guo-dong Gao, M.D.</last_name>
      <phone>+86 29 84777435</phone>
      <email>gguodong@fmmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Xue-lian Wang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2011</study_first_submitted>
  <study_first_submitted_qc>January 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2011</study_first_posted>
  <last_update_submitted>April 14, 2014</last_update_submitted>
  <last_update_submitted_qc>April 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tang-Du Hospital</investigator_affiliation>
    <investigator_full_name>Guodong Gao</investigator_full_name>
    <investigator_title>Department of Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Opiate dependence</keyword>
  <keyword>Deep brain stimulation</keyword>
  <keyword>Nucleus accumbens</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methadone</mesh_term>
    <mesh_term>Opiate Alkaloids</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 9, 2017</submitted>
    <returned>March 28, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

